• Dry Cracked Skin
  • General Dermatology
  • Impetigo
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Surgery
  • Melasma
  • NP and PA
  • Anti-Aging
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Inflamed Skin

Canada OKs Cutera's Excel V laser system

Article

Cutera has announced that Canadian regulatory agency Health Canada has approved the company’s Excel V laser for vascular, pigment and overall skin-rejuvenation treatments, Globe Newswire reports.

Brisbane, Calif. - Cutera has announced that Canadian regulatory agency Health Canada has approved the company’s Excel V laser for vascular, pigment and overall skin-rejuvenation treatments, Globe Newswire reports.

The Excel V system features a dual wavelength platform. One handpiece includes a 532 nm laser for superficial vessels and pigments, and a 1,064 nm Nd:YAG laser to treat leg veins, port wine stains and hemangiomas. The second handpiece, for facial rejuvenation, affords a collagen-producing solution for fine lines, uneven texture and premature aging.

The Excel V also features ergonomic handpieces, a solid-state design and a sapphire window with real-time calibration and spot size adjustment, enabling the precise targeting of lesions, the company states.

Go back to the Dermatology Times eNews newsletter.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.